Multiple Sclerosis Clinical Trial
Official title:
MS Ballroom Fitness - Benefits of a Personalized Dance-based Concept on Balance, Walking Capacity, and Well-being in Multiple Sclerosis
Verified date | August 2023 |
Source | University of Aarhus |
Contact | Lars Hvid |
Phone | 93508717 |
lhvid[@]ph.au.dk | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of the present study is to evaluate the effects of a dance-based concept entitled MS Ballroom Fitness (developed in Denmark by PT Elisabeth Dalsgaard) in persons with multiple sclerosis (pwMS). A total of 66 pwMS will be enrolled and equally randomized into an intervention group or a control-waitlist group. Those in the intervention group will undertake 7 weeks of MS Ballroom Fitness, with 2 sessions per week. The investigators assume that balance, walking capacity as well as well-being will be improved.
Status | Recruiting |
Enrollment | 66 |
Est. completion date | December 22, 2023 |
Est. primary completion date | December 22, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - self-reported MS diagnosis - patient-determined disease steps (PDDS) = 7 (7 correspond to use a wheelchair for most daily activities) - able to independently attend the testing Exclusion Criteria: - self-reported comorbidities excluding participation in the intervention - substantial cognitive impairments hindering participation - recent fractures (6 months) - critical physical impairments hindering participation in the described training study - participation in structured exercise therapy (including dancing) for the past 3 months (= 2 session per week of moderate-to-high intensity) |
Country | Name | City | State |
---|---|---|---|
Denmark | Aarhus University, Exercise Biology | Aarhus C | Jutland |
Lead Sponsor | Collaborator |
---|---|
University of Aarhus | The Danish MS Society |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Six spot step test (SSST) | Objective test that measures walking coordination and balance. Unit: seconds. | Change from Baseline to 7 weeks | |
Primary | WHO5 wellbeing | Questionnaire that measures current mental well-being. Unit: score (0-100; 100 is better). | Change from Baseline to 7 weeks | |
Secondary | Static balance | Objective test that measures static balance (total score based on 5 different tests; 10s parallel foot stand, 10s semi-parallel foot stand, 10s tandem foot stand, 20s right leg foot stand, 20s left leg foot stand). Unit: seconds (0-70s; 70s is better) | Change from Baseline to 7 weeks | |
Secondary | Functional reach test | Objective test that measures how far a person can reach with one arm in standing position. Unit: cm. | Change from Baseline to 7 weeks | |
Secondary | Modified functional reach test | Objective test that measures how far a person can reach (forward, left, right) with one arm in sitting position. Unit: cm.
NB: This test is used for wheel-chair users only. |
Change from Baseline to 7 weeks | |
Secondary | Four square step test | Objective test that measures dynamic stability and co-ordination. Unit: s. | Change from Baseline to 7 weeks | |
Secondary | 6-minute walk test | Objective test that measures walking endurance. Unit: meters. | Change from Baseline to 7 weeks | |
Secondary | Ottawa sitting scale | Rater-evaluated test that measures the level of trunk impairments and sitting balance. Unit: score (0-24; 24 is better).
NB: This test is used for wheel-chair users only. |
Change from Baseline to 7 weeks | |
Secondary | Patient determined disease steps | Questionnaire that measures level of disability in multiple sclerosis. Unit: score (0-8; 0 is better). | Change from Baseline to 7 weeks | |
Secondary | Multiple Sclerosis Walking Scale | Questionnaire that measures walking limitations in multiple sclerosis. Unit: score (0-100; 0 is better). | Change from Baseline to 7 weeks | |
Secondary | European Quality of life - 5 Dimensions (EuroQOL5D) | Questionnaire that measures quality of life. Unit: score (0-100; 0 is better). | Change from Baseline to 7 weeks | |
Secondary | Modified fatigue impact scale | Questionnaire that measures the impact fatigue has on daily life. Unit: score (0-84; 0 is better) | Change from Baseline to 7 weeks | |
Secondary | Falls-efficacy scale - international | Questionnaire that measures concerns about falling. Unit: score (16-64; 16 is better) | Change from Baseline to 7 weeks | |
Secondary | Falls | Number of falls in the past year | Change from Baseline to 7 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |